Publisher
Florida Atlantic University
Description
Anticancer drugs, including nocodazole and vinblastine, work by disrupting the dynamics of microtubules. Unfortunately, these drugs often produce numerous side effects, including nausea, vomiting, loss of appetite, loss of hair, increased chance of infection, and fatigue. My thesis research evaluated the efficacy of using repeated low doses of microtubule drugs instead of a single high dose, in an attempt to minimize side effects. Using nocodazole and vinblastine, I first established the minimum effective concentration that disrupts the microtubules in normal human cells grown in vitro and treated cells with those concentrations over a period of several days. I found that microtubules were increasingly depolymerized as the days progressed. Next, I tested a combination of nocodazole and vinblastine at low concentrations.
Extent
vi, 16 leaves : ill. (some col.) ; 29 cm.
Rights
Copyright © is held by the author, with permission granted to Florida Atlantic University to digitize, archive and distribute this item for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires permission of the copyright holder.
Extension
FAU
FAU
admin_unit="FAU01", ingest_id="ing3854", creator="creator:SPATEL", creation_date="2009-06-08 13:38:51", modified_by="super:FAUDIG", modification_date="2012-06-05 11:59:11"
Physical Description
electronic
electronic resource
vi, 16 leaves : ill. (some col.) ; 29 cm.
Title Plain
Alternate applications of anticancer drugs on COS-7 normal cells
Use and Reproduction
Copyright © is held by the author, with permission granted to Florida Atlantic University to digitize, archive and distribute this item for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires permission of the copyright holder.
Title
Alternate applications of anticancer drugs on COS-7 normal cells
Other Title Info
Alternate applications of anticancer drugs on COS-7 normal cells